1.
Ippoliti PJ, Kuhn E, Mani DR, et al. Automated Microchromatography Enables Multiplexing of Immunoaffinity Enrichment of Peptides to Greater than 150 for Targeted MS-Based Assays. Anal Chem. 2016;88(15):7548-55. doi:10.1021/acs.analchem.6b00946.
1.
Smith G, Gerszten RE. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease. Circulation. 2017;135(17):1651-1664. doi:10.1161/CIRCULATIONAHA.116.025446.
1.
Santos AF, Shreffler WG. Road map for the clinical application of the basophil activation test in food allergy. Clin Exp Allergy. 2017;47(9):1115-1124. doi:10.1111/cea.12964.
1.
Boisen ML, Hartnett JN, Shaffer JG, et al. Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever. Sci Rep. 2018;8(1):5939. doi:10.1038/s41598-018-24246-w.
1.
Regnier FE, Skates SJ, Mesri M, et al. Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. Clin Chem. 2010;56(2):165-71. doi:10.1373/clinchem.2009.140087.
1.
Whiteaker JR, Zhao L, Abbatiello SE, et al. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol Cell Proteomics. 2011;10(4):M110.005645. doi:10.1074/mcp.M110.005645.
1.
Zhao L, Whiteaker JR, Pope ME, et al. Quantification of proteins using peptide immunoaffinity enrichment coupled with mass spectrometry. J Vis Exp. 2011;(53). doi:10.3791/2812.
1.
Shaffer JG, Grant DS, Schieffelin JS, et al. Lassa fever in post-conflict sierra leone. PLoS Negl Trop Dis. 2014;8(3):e2748. doi:10.1371/journal.pntd.0002748.
1.
Valim C, Ahmad R, Lanaspa M, et al. Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia. Am J Respir Crit Care Med. 2016;193(4):448-59. doi:10.1164/rccm.201506-1100OC.
1.
Cleynen I, Boucher G, Jostins L, et al. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016;387(10014):156-67. doi:10.1016/S0140-6736(15)00465-1.